当前干细胞报告 SCIE

期刊简介预计审稿时间：

the Goal Of This Journal Is To Publish Cutting-edge Reviews On Subjects Pertinent To All Aspects Of Stem Cell Research, Therapy, Ethics, Commercialization, And Policy. We Aim To Provide Incisive, Insightful, And Balanced Contributions From Leading Experts In Each Relevant Domain That Will Be Of Immediate Interest To A Wide Readership Of Clinicians, Basic Scientists, And Translational Investigators.

we Accomplish This Aim By Appointing Major Authorities To Serve As Section Editors In Key Subject Areas Across The Discipline. Section Editors Select Topics To Be Reviewed By Leading Experts Who Emphasize Recent Developments And Highlight Important Papers Published Over The Past Year On Their Topics, In A Crisp And Readable Format. We Also Provide Commentaries From Well-known Figures In The Field, And An Editorial Board Of Internationally Diverse Members Suggests Topics Of Special Interest To Their Country/region And Ensures That Topics Are Current And Include Emerging Research.

本期刊的目标是发表与干细胞研究、治疗、伦理、商业化和政策等各方面相关的前沿评论。我们的目标是提供来自各个相关领域的顶尖专家的深刻、有见地和平衡的贡献，这些贡献将立即引起广大临床医生、基础科学家和转化研究人员的兴趣。

我们通过任命主要权威人士担任该学科关键学科领域的部门编辑来实现这一目标。部门编辑选择由顶尖专家审查的主题，这些专家强调最近的发展，并以简洁易读的格式突出过去一年就其主题发表的重要论文。我们还提供该领域知名人物的评论，由来自世界各地的成员组成的编辑委员会会建议其国家/地区特别感兴趣的主题，并确保主题是最新且包含新兴研究。

如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。